Neuromuscular Monitoring, Muscle Relaxant Use, and Reversal at a Tertiary Teaching Hospital 2.5 Years after Introduction of Sugammadex: Changes in Opinions and Clinical Practice
Sugammadex was introduced to Royal Perth Hospital in early 2011 without access restriction. Two departmental audits (26-page online survey and 1-week in-theatre snapshot audit) were undertaken to investigate the change of beliefs and clinical practice related to the use of neuromuscular blocking age...
Main Authors: | Thomas Ledowski, Jing Shen Ong, Tom Flett |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Anesthesiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/367937 |
Similar Items
-
Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
by: Thomas Ledowski, et al.
Published: (2013-01-01) -
Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex
by: Sorin J Brull, et al.
Published: (2009-04-01) -
The safety and necessity of Sugammadex in neuromuscular blockade reversal
by: Liu, Yitao
Published: (2015) -
Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
by: Mehdi Trifa, et al.
Published: (2017-01-01) -
Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment
by: D Chambers, et al.
Published: (2010-07-01)